Akebia Therapeutics
AKBA
#6961
Rank
A$0.61 B
Marketcap
$2.94
Share price
4.02%
Change (1 day)
110.31%
Change (1 year)

Akebia Therapeutics (AKBA) Fails to deliver data

Key failure to deliver metrics for Akebia Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Akebia Therapeutics (AKBA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Akebia Therapeutics (AKBA) - since 2014

Volume in USD (price x number of shares), data since 2014

Akebia Therapeutics (AKBA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$4.58 M70.9%
2023A$2.68 M-41.28%
2022A$4.56 M8.92%
2021A$4.19 M-18.58%
2020A$5.15 M43.43%
2019A$3.59 M-62.25%
2018A$9.51 M238.71%
2017A$2.8 M-25.14%
2016A$3.75 M92.2%
2015A$1.95 M-88.22%
2014A$16.56 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$56.79 MA$0.30 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.44 MA$78.49 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$70.4 MA$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.03 MA$0.15 M๐Ÿ‡บ๐Ÿ‡ธ USA